Basic Information
Zikani Therapeutics leverages the highly efficient chemical platform TURBO-ZM to generate novel, orally bioavailable small molecule RMAs, which Zikani can optimize to target human ribosomes in a disease-specific manner.
Zikani Therapeutics, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2015
info@Zikani.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios